Articles from Evosep

TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- HUPO World Congress – Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of LCMS based proteomics most persistent challenges: sample preparation. Building on its legacy of standardizing proteomics LC separation, Evosep is now expanding upstream to deliver robust, and reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics.

SAINT-MALO, France, June 17, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMIC-Assist Study—the world’s largest multi-omic precision medicine initiative, launched by P4ML alongside its strategic academic, health regulatory, and semi-state partners in the United Arab Emirates.

BALTIMORE, Md., June 02, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in proteomics solutions, is proud to announce the launch of the Evosep Eno™, a robust, high-throughput separation tool preparing for next generation workflow integration for LC-MS based proteomics. This new platform will significantly enhance the company’s ability to advance the use of LC-MS based proteomics as a vital tool for the pharmaceutical and biotech industries. In addition, Evosep has entered into a reseller agreement with SCIEX to support pharmaceutical companies in analyzing a broader range of drug modalities more efficiently and at greater scale.